

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.30322345 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.30322345 |
| 3 | aromatic amino acid family catabolic process (GO:0009074) | 6.18364180 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.08215158 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.08215158 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.08128447 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.08128447 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.08128447 |
| 9 | tryptophan metabolic process (GO:0006568) | 5.66389694 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.45582529 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.42560361 |
| 12 | urea cycle (GO:0000050) | 5.42084404 |
| 13 | urea metabolic process (GO:0019627) | 5.42084404 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.21905429 |
| 15 | nitrogen cycle metabolic process (GO:0071941) | 4.93817238 |
| 16 | cysteine metabolic process (GO:0006534) | 4.92249123 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 4.79886669 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 4.77146319 |
| 19 | coenzyme catabolic process (GO:0009109) | 4.67333782 |
| 20 | complement activation, alternative pathway (GO:0006957) | 4.65811436 |
| 21 | cellular ketone body metabolic process (GO:0046950) | 4.62959745 |
| 22 | glyoxylate metabolic process (GO:0046487) | 4.62819082 |
| 23 | regulation of protein activation cascade (GO:2000257) | 4.61698793 |
| 24 | cellular glucuronidation (GO:0052695) | 4.57736815 |
| 25 | homocysteine metabolic process (GO:0050667) | 4.52014201 |
| 26 | bile acid metabolic process (GO:0008206) | 4.50126993 |
| 27 | aromatic amino acid family metabolic process (GO:0009072) | 4.47053218 |
| 28 | indolalkylamine metabolic process (GO:0006586) | 4.37582220 |
| 29 | regulation of complement activation (GO:0030449) | 4.37526041 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.33100779 |
| 31 | glucuronate metabolic process (GO:0019585) | 4.32751512 |
| 32 | uronic acid metabolic process (GO:0006063) | 4.32751512 |
| 33 | amine catabolic process (GO:0009310) | 4.32260685 |
| 34 | cellular biogenic amine catabolic process (GO:0042402) | 4.32260685 |
| 35 | high-density lipoprotein particle remodeling (GO:0034375) | 4.28005117 |
| 36 | regulation of female gonad development (GO:2000194) | 4.26310550 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.25928321 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.17997619 |
| 39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.15191458 |
| 40 | protein carboxylation (GO:0018214) | 4.15191458 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.07590587 |
| 42 | bile acid and bile salt transport (GO:0015721) | 4.01878306 |
| 43 | drug catabolic process (GO:0042737) | 3.98909453 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 3.96017964 |
| 45 | ketone body metabolic process (GO:1902224) | 3.95851711 |
| 46 | ethanol oxidation (GO:0006069) | 3.95787240 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 3.94150064 |
| 48 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.94114163 |
| 49 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.94114163 |
| 50 | lysine metabolic process (GO:0006553) | 3.92696447 |
| 51 | lysine catabolic process (GO:0006554) | 3.92696447 |
| 52 | imidazole-containing compound metabolic process (GO:0052803) | 3.91673492 |
| 53 | triglyceride homeostasis (GO:0070328) | 3.91505473 |
| 54 | acylglycerol homeostasis (GO:0055090) | 3.91505473 |
| 55 | negative regulation of fibrinolysis (GO:0051918) | 3.89306886 |
| 56 | NAD biosynthetic process (GO:0009435) | 3.84779166 |
| 57 | regulation of fibrinolysis (GO:0051917) | 3.81815111 |
| 58 | aldehyde catabolic process (GO:0046185) | 3.81118168 |
| 59 | regulation of cholesterol esterification (GO:0010872) | 3.72297446 |
| 60 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.71887190 |
| 61 | arginine metabolic process (GO:0006525) | 3.71071917 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66244550 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 3.66244550 |
| 64 | macromolecular complex remodeling (GO:0034367) | 3.66244550 |
| 65 | peroxisome fission (GO:0016559) | 3.64684168 |
| 66 | reverse cholesterol transport (GO:0043691) | 3.63969852 |
| 67 | complement activation, classical pathway (GO:0006958) | 3.63582555 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.60027738 |
| 69 | cofactor catabolic process (GO:0051187) | 3.59787075 |
| 70 | fibrinolysis (GO:0042730) | 3.58498640 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.58404565 |
| 72 | phospholipid efflux (GO:0033700) | 3.58220685 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 3.55118931 |
| 74 | piRNA metabolic process (GO:0034587) | 3.49385583 |
| 75 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.45602030 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.44101908 |
| 77 | linoleic acid metabolic process (GO:0043651) | 3.43934830 |
| 78 | negative regulation of lipase activity (GO:0060192) | 3.41657812 |
| 79 | complement activation (GO:0006956) | 3.37797429 |
| 80 | acetyl-CoA metabolic process (GO:0006084) | 3.35708528 |
| 81 | exogenous drug catabolic process (GO:0042738) | 3.31862586 |
| 82 | citrulline biosynthetic process (GO:0019240) | 3.31698648 |
| 83 | regulation of sequestering of triglyceride (GO:0010889) | 3.29890496 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.27079626 |
| 85 | opsonization (GO:0008228) | 3.26706971 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.26302972 |
| 87 | glutamate metabolic process (GO:0006536) | 3.26269328 |
| 88 | glycine metabolic process (GO:0006544) | 3.26048940 |
| 89 | cytolysis (GO:0019835) | 3.25237126 |
| 90 | protein activation cascade (GO:0072376) | 3.20565602 |
| 91 | cholesterol efflux (GO:0033344) | 3.20085686 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.19539601 |
| 93 | organic acid catabolic process (GO:0016054) | 3.19539601 |
| 94 | regulation of bile acid biosynthetic process (GO:0070857) | 3.17051463 |
| 95 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.13700725 |
| 96 | NAD metabolic process (GO:0019674) | 3.13224895 |
| 97 | sulfur amino acid metabolic process (GO:0000096) | 3.12585831 |
| 98 | negative regulation of sterol transport (GO:0032372) | 3.09282637 |
| 99 | negative regulation of cholesterol transport (GO:0032375) | 3.09282637 |
| 100 | response to nitrosative stress (GO:0051409) | 3.07790730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.56334631 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.54391265 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.24190511 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.15061000 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.13662270 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.66333181 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.97017013 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.86814365 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.70684119 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.54803468 |
| 11 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.26075498 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.23372901 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.08695395 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.04276624 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.91967502 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.75997087 |
| 17 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.68611961 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65493333 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.64989431 |
| 20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.63814141 |
| 21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59607102 |
| 22 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.57674715 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56174533 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55745489 |
| 25 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47470044 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47336846 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.46531507 |
| 28 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.40556601 |
| 29 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.37939701 |
| 30 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35328944 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34706120 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32864452 |
| 33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.30140250 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29828598 |
| 35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27562493 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25429797 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24664202 |
| 38 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18190703 |
| 39 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17956511 |
| 40 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17687207 |
| 41 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16717012 |
| 42 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15658461 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14349663 |
| 44 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.14333371 |
| 45 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13119993 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12494792 |
| 47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.10831886 |
| 48 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10520226 |
| 49 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10170881 |
| 50 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09631168 |
| 51 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08875613 |
| 52 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07902280 |
| 53 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07586257 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05951968 |
| 55 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05146181 |
| 56 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03915512 |
| 57 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03499924 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02702657 |
| 59 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02523235 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01990362 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01909643 |
| 62 | JUN_21703547_ChIP-Seq_K562_Human | 1.01833273 |
| 63 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.01715713 |
| 64 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01227983 |
| 65 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01139570 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00649229 |
| 67 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00174800 |
| 68 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.99690330 |
| 69 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98705972 |
| 70 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.98648750 |
| 71 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98331391 |
| 72 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98032183 |
| 73 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97665070 |
| 74 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.96417748 |
| 75 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95809072 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95697470 |
| 77 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95244702 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95244702 |
| 79 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.95210776 |
| 80 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.94758947 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92617379 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90514206 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90350826 |
| 84 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.89995111 |
| 85 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.89815243 |
| 86 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.89081420 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88908009 |
| 88 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.88457597 |
| 89 | NFYA_21822215_ChIP-Seq_K562_Human | 0.88074414 |
| 90 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.87912215 |
| 91 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.87591195 |
| 92 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.85872504 |
| 93 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.84435322 |
| 94 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84416998 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84374340 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.84374340 |
| 97 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.83604005 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83140258 |
| 99 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82732432 |
| 100 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82706905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.92852767 |
| 2 | MP0005360_urolithiasis | 6.68203323 |
| 3 | MP0005365_abnormal_bile_salt | 5.60558800 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.56691378 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.65623460 |
| 6 | MP0005451_abnormal_body_composition | 3.80356151 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.48751558 |
| 8 | MP0003718_maternal_effect | 3.45186939 |
| 9 | MP0003252_abnormal_bile_duct | 3.34194822 |
| 10 | MP0003646_muscle_fatigue | 3.17390277 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.78627215 |
| 12 | MP0005332_abnormal_amino_acid | 2.42087841 |
| 13 | MP0009697_abnormal_copulation | 2.29117337 |
| 14 | MP0009840_abnormal_foam_cell | 2.19066620 |
| 15 | MP0003195_calcinosis | 2.10661068 |
| 16 | MP0001984_abnormal_olfaction | 1.97990863 |
| 17 | MP0001666_abnormal_nutrient_absorption | 1.91066762 |
| 18 | MP0003868_abnormal_feces_composition | 1.72882975 |
| 19 | MP0005647_abnormal_sex_gland | 1.68502106 |
| 20 | MP0000609_abnormal_liver_physiology | 1.62456966 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.62291506 |
| 22 | MP0005083_abnormal_biliary_tract | 1.56928763 |
| 23 | MP0005395_other_phenotype | 1.50166341 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.47397171 |
| 25 | MP0003699_abnormal_female_reproductive | 1.41270018 |
| 26 | MP0000566_synostosis | 1.41065538 |
| 27 | MP0001119_abnormal_female_reproductive | 1.40103497 |
| 28 | MP0002638_abnormal_pupillary_reflex | 1.37742764 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.34122902 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.31411660 |
| 31 | MP0009764_decreased_sensitivity_to | 1.31292430 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.30646126 |
| 33 | MP0001529_abnormal_vocalization | 1.29981604 |
| 34 | MP0003186_abnormal_redox_activity | 1.27485850 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.26520474 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.24689823 |
| 37 | MP0005408_hypopigmentation | 1.21400178 |
| 38 | MP0001764_abnormal_homeostasis | 1.19780488 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.12612490 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.11482352 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.10749498 |
| 42 | MP0000579_abnormal_nail_morphology | 1.08481652 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.04319431 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.03118691 |
| 45 | MP0005187_abnormal_penis_morphology | 1.03103024 |
| 46 | MP0005220_abnormal_exocrine_pancreas | 0.93025029 |
| 47 | MP0002971_abnormal_brown_adipose | 0.90162281 |
| 48 | MP0000639_abnormal_adrenal_gland | 0.90114339 |
| 49 | MP0002249_abnormal_larynx_morphology | 0.89825638 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 0.89023611 |
| 51 | MP0005266_abnormal_metabolism | 0.81238620 |
| 52 | MP0000598_abnormal_liver_morphology | 0.80284208 |
| 53 | MP0004130_abnormal_muscle_cell | 0.78852342 |
| 54 | MP0005084_abnormal_gallbladder_morpholo | 0.76505775 |
| 55 | MP0004142_abnormal_muscle_tone | 0.76332077 |
| 56 | MP0000653_abnormal_sex_gland | 0.73976798 |
| 57 | MP0005535_abnormal_body_temperature | 0.72731278 |
| 58 | MP0001929_abnormal_gametogenesis | 0.71882584 |
| 59 | MP0001905_abnormal_dopamine_level | 0.71100649 |
| 60 | MP0001919_abnormal_reproductive_system | 0.70845143 |
| 61 | MP0009763_increased_sensitivity_to | 0.70265096 |
| 62 | MP0002078_abnormal_glucose_homeostasis | 0.69515992 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 0.67843053 |
| 64 | MP0005334_abnormal_fat_pad | 0.66858217 |
| 65 | MP0002210_abnormal_sex_determination | 0.63349398 |
| 66 | MP0009642_abnormal_blood_homeostasis | 0.63015032 |
| 67 | MP0001502_abnormal_circadian_rhythm | 0.62942515 |
| 68 | MP0009643_abnormal_urine_homeostasis | 0.61634942 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 0.60570499 |
| 70 | MP0009765_abnormal_xenobiotic_induced | 0.59684991 |
| 71 | MP0005389_reproductive_system_phenotype | 0.59232713 |
| 72 | MP0005376_homeostasis/metabolism_phenot | 0.58764932 |
| 73 | MP0002102_abnormal_ear_morphology | 0.57930357 |
| 74 | MP0006276_abnormal_autonomic_nervous | 0.57168676 |
| 75 | MP0003890_abnormal_embryonic-extraembry | 0.57136951 |
| 76 | MP0005636_abnormal_mineral_homeostasis | 0.56745386 |
| 77 | MP0008874_decreased_physiological_sensi | 0.55102538 |
| 78 | MP0000613_abnormal_salivary_gland | 0.53904663 |
| 79 | MP0002161_abnormal_fertility/fecundity | 0.53175984 |
| 80 | MP0002736_abnormal_nociception_after | 0.52097320 |
| 81 | MP0005248_abnormal_Harderian_gland | 0.52075456 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.51972068 |
| 83 | MP0008469_abnormal_protein_level | 0.51525925 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.48901835 |
| 85 | MP0005166_decreased_susceptibility_to | 0.46041406 |
| 86 | MP0003937_abnormal_limbs/digits/tail_de | 0.45533123 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 0.44366215 |
| 88 | MP0005257_abnormal_intraocular_pressure | 0.43634501 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.43633766 |
| 90 | MP0003011_delayed_dark_adaptation | 0.42580165 |
| 91 | MP0001915_intracranial_hemorrhage | 0.42439335 |
| 92 | MP0003953_abnormal_hormone_level | 0.42232292 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.41444812 |
| 94 | MP0002269_muscular_atrophy | 0.37901624 |
| 95 | MP0002653_abnormal_ependyma_morphology | 0.37427146 |
| 96 | MP0005197_abnormal_uvea_morphology | 0.35593222 |
| 97 | MP0005499_abnormal_olfactory_system | 0.35393966 |
| 98 | MP0005394_taste/olfaction_phenotype | 0.35393966 |
| 99 | MP0008789_abnormal_olfactory_epithelium | 0.35026464 |
| 100 | MP0002928_abnormal_bile_duct | 0.35020831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.44219217 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.20978180 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 6.16766906 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.87090369 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.96710049 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.60117930 |
| 7 | Complement deficiency (HP:0004431) | 4.47183537 |
| 8 | Xanthomatosis (HP:0000991) | 4.42303068 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.23871009 |
| 10 | Hyperglycinemia (HP:0002154) | 4.10869129 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.06837143 |
| 12 | Hyperglycinuria (HP:0003108) | 3.73689608 |
| 13 | Abnormality of methionine metabolism (HP:0010901) | 3.72110617 |
| 14 | Fat malabsorption (HP:0002630) | 3.71512813 |
| 15 | Ketosis (HP:0001946) | 3.69321446 |
| 16 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.67079637 |
| 17 | Hyperammonemia (HP:0001987) | 3.65347480 |
| 18 | Conjugated hyperbilirubinemia (HP:0002908) | 3.64699121 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.62071118 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.60577334 |
| 21 | Epidermoid cyst (HP:0200040) | 3.48947679 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.46334776 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.46334776 |
| 24 | Joint hemorrhage (HP:0005261) | 3.39997177 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.34195080 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.34044383 |
| 27 | Male infertility (HP:0003251) | 3.33496447 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.32390957 |
| 29 | Abnormality of serum amino acid levels (HP:0003112) | 3.19013918 |
| 30 | Acanthocytosis (HP:0001927) | 3.15821779 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.14786115 |
| 32 | Renal cortical cysts (HP:0000803) | 3.13480560 |
| 33 | Ketoacidosis (HP:0001993) | 3.10691693 |
| 34 | Steatorrhea (HP:0002570) | 3.10666759 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.09352398 |
| 36 | Spontaneous abortion (HP:0005268) | 3.06004214 |
| 37 | Hypoglycemic coma (HP:0001325) | 3.03998625 |
| 38 | Cholecystitis (HP:0001082) | 3.03420021 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 3.03420021 |
| 40 | Abnormality of complement system (HP:0005339) | 3.01130829 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 2.96547548 |
| 42 | Hypoalphalipoproteinemia (HP:0003233) | 2.88860822 |
| 43 | Hypercholesterolemia (HP:0003124) | 2.74535956 |
| 44 | Generalized aminoaciduria (HP:0002909) | 2.74501195 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.68083800 |
| 46 | Papillary thyroid carcinoma (HP:0002895) | 2.61221634 |
| 47 | Hyperbilirubinemia (HP:0002904) | 2.61146886 |
| 48 | Brushfield spots (HP:0001088) | 2.53143339 |
| 49 | Bile duct proliferation (HP:0001408) | 2.48319467 |
| 50 | Abnormal biliary tract physiology (HP:0012439) | 2.48319467 |
| 51 | Metabolic acidosis (HP:0001942) | 2.48105558 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45918792 |
| 53 | Lethargy (HP:0001254) | 2.43687872 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 2.42196491 |
| 55 | Cortical dysplasia (HP:0002539) | 2.38666388 |
| 56 | Enlarged kidneys (HP:0000105) | 2.36120268 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.35028160 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.34126130 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34126130 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.33598415 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.29050011 |
| 62 | Fair hair (HP:0002286) | 2.26999716 |
| 63 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.20648620 |
| 64 | Proximal tubulopathy (HP:0000114) | 2.19053765 |
| 65 | Cholelithiasis (HP:0001081) | 2.14533303 |
| 66 | Delayed CNS myelination (HP:0002188) | 2.03973384 |
| 67 | Hydroxyprolinuria (HP:0003080) | 2.03649550 |
| 68 | Abnormality of proline metabolism (HP:0010907) | 2.03649550 |
| 69 | Irritability (HP:0000737) | 2.02517773 |
| 70 | Malnutrition (HP:0004395) | 2.00865434 |
| 71 | Abnormality of the gallbladder (HP:0005264) | 2.00180596 |
| 72 | Cerebral edema (HP:0002181) | 2.00052266 |
| 73 | Hyperglycemia (HP:0003074) | 1.99847741 |
| 74 | Hypochromic microcytic anemia (HP:0004840) | 1.97978601 |
| 75 | Gout (HP:0001997) | 1.94950587 |
| 76 | Late onset (HP:0003584) | 1.94911455 |
| 77 | Opisthotonus (HP:0002179) | 1.94892193 |
| 78 | Hypergonadotropic hypogonadism (HP:0000815) | 1.94323769 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 1.94030891 |
| 80 | Sensorimotor neuropathy (HP:0007141) | 1.92930140 |
| 81 | Azoospermia (HP:0000027) | 1.92408036 |
| 82 | Myocardial infarction (HP:0001658) | 1.89533279 |
| 83 | Poikilocytosis (HP:0004447) | 1.88752823 |
| 84 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.88238359 |
| 85 | Abnormality of urine glucose concentration (HP:0011016) | 1.85794181 |
| 86 | Glycosuria (HP:0003076) | 1.85794181 |
| 87 | Progressive external ophthalmoplegia (HP:0000590) | 1.85164344 |
| 88 | Abnormal tarsal ossification (HP:0008369) | 1.78194188 |
| 89 | Adrenal hypoplasia (HP:0000835) | 1.76327895 |
| 90 | Increased purine levels (HP:0004368) | 1.76188773 |
| 91 | Hyperuricemia (HP:0002149) | 1.76188773 |
| 92 | Respiratory distress (HP:0002098) | 1.75853489 |
| 93 | Skin nodule (HP:0200036) | 1.74518903 |
| 94 | Chorioretinal atrophy (HP:0000533) | 1.72528744 |
| 95 | Acute hepatic failure (HP:0006554) | 1.71880358 |
| 96 | Abnormality of the renal cortex (HP:0011035) | 1.71404281 |
| 97 | Hepatic necrosis (HP:0002605) | 1.70914498 |
| 98 | Methylmalonic aciduria (HP:0012120) | 1.70644836 |
| 99 | Hyperventilation (HP:0002883) | 1.69700745 |
| 100 | Vomiting (HP:0002013) | 1.69437251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K6 | 4.56045719 |
| 2 | STK38L | 4.31117718 |
| 3 | ERBB4 | 4.00659221 |
| 4 | TAOK3 | 3.95672605 |
| 5 | LATS2 | 3.25283692 |
| 6 | LATS1 | 3.16797658 |
| 7 | BRAF | 3.06912830 |
| 8 | MAP3K13 | 2.89209637 |
| 9 | MAP2K7 | 2.48409190 |
| 10 | BMPR2 | 2.34802431 |
| 11 | BCKDK | 2.32717380 |
| 12 | CDK8 | 2.25521726 |
| 13 | MAP2K4 | 2.25114912 |
| 14 | MOS | 2.12528214 |
| 15 | ARAF | 1.93834847 |
| 16 | AKT3 | 1.93356221 |
| 17 | MAP3K9 | 1.84357368 |
| 18 | SGK2 | 1.73545321 |
| 19 | PLK4 | 1.66270071 |
| 20 | MAP3K4 | 1.63056688 |
| 21 | MAP3K5 | 1.62833539 |
| 22 | DYRK2 | 1.61234080 |
| 23 | KSR2 | 1.49350599 |
| 24 | MAPK13 | 1.47097220 |
| 25 | MUSK | 1.46344886 |
| 26 | MELK | 1.41710247 |
| 27 | MAP3K12 | 1.38621130 |
| 28 | PIK3CG | 1.35784394 |
| 29 | ABL2 | 1.34622952 |
| 30 | CSNK1G1 | 1.31844865 |
| 31 | TTK | 1.21644150 |
| 32 | PINK1 | 1.21496285 |
| 33 | INSRR | 1.18250773 |
| 34 | SGK223 | 1.16967058 |
| 35 | SGK494 | 1.16967058 |
| 36 | CSNK1A1L | 1.15096768 |
| 37 | CSNK1G2 | 1.03196437 |
| 38 | MAPK11 | 1.02914732 |
| 39 | STK24 | 1.02323167 |
| 40 | CSNK1G3 | 1.01895968 |
| 41 | NLK | 0.99706703 |
| 42 | PRKAA1 | 0.92590186 |
| 43 | SIK1 | 0.88523049 |
| 44 | CHEK2 | 0.87165986 |
| 45 | OBSCN | 0.86963832 |
| 46 | STK3 | 0.86846563 |
| 47 | SGK3 | 0.86842485 |
| 48 | TAOK1 | 0.84608040 |
| 49 | RAF1 | 0.83383332 |
| 50 | CDK9 | 0.78999262 |
| 51 | PRKAA2 | 0.78988024 |
| 52 | NEK9 | 0.75274912 |
| 53 | CDK3 | 0.69148402 |
| 54 | CAMK2A | 0.65147700 |
| 55 | STK38 | 0.64951738 |
| 56 | MAP3K14 | 0.64016780 |
| 57 | JAK3 | 0.63946468 |
| 58 | KSR1 | 0.63133235 |
| 59 | JAK2 | 0.58848453 |
| 60 | PLK2 | 0.55337443 |
| 61 | PBK | 0.54859771 |
| 62 | BMPR1B | 0.54737383 |
| 63 | NTRK2 | 0.52585285 |
| 64 | FGR | 0.47771646 |
| 65 | ADRBK2 | 0.45078744 |
| 66 | FRK | 0.43560518 |
| 67 | CAMK2G | 0.43415384 |
| 68 | TAOK2 | 0.43125699 |
| 69 | ABL1 | 0.42881934 |
| 70 | PLK1 | 0.42204849 |
| 71 | FGFR4 | 0.40874005 |
| 72 | IRAK2 | 0.39835621 |
| 73 | EIF2AK1 | 0.38730997 |
| 74 | AKT2 | 0.36508877 |
| 75 | SIK3 | 0.35956813 |
| 76 | MST1R | 0.34240969 |
| 77 | PRKCQ | 0.33761867 |
| 78 | TYK2 | 0.33343327 |
| 79 | IRAK1 | 0.31924459 |
| 80 | PRKD3 | 0.31330680 |
| 81 | RET | 0.30538880 |
| 82 | PHKG1 | 0.27884730 |
| 83 | PHKG2 | 0.27884730 |
| 84 | PLK3 | 0.27526168 |
| 85 | PKN1 | 0.26376745 |
| 86 | SGK1 | 0.26167049 |
| 87 | PRKCZ | 0.26150263 |
| 88 | KIT | 0.25234446 |
| 89 | PDPK1 | 0.22445010 |
| 90 | PTK2B | 0.22038481 |
| 91 | AURKA | 0.22016921 |
| 92 | JAK1 | 0.21067944 |
| 93 | PDK1 | 0.20964368 |
| 94 | AURKB | 0.20619119 |
| 95 | HIPK2 | 0.20361419 |
| 96 | NUAK1 | 0.19884895 |
| 97 | CSNK1A1 | 0.19408692 |
| 98 | PRKD2 | 0.18905716 |
| 99 | PRKCG | 0.18279294 |
| 100 | CDK6 | 0.17464076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.66130224 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33552202 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32483028 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79484283 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69540136 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65008291 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55337599 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52957455 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45654145 |
| 10 | Peroxisome_Homo sapiens_hsa04146 | 2.45150632 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42879970 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40014530 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.37810012 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.12422202 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.12292777 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06968906 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99525935 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.98199866 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97068510 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95804633 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89266628 |
| 22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.87910009 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78888889 |
| 24 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.77490940 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74601973 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72724604 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70831224 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.69044966 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.67804976 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65778216 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64084426 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63212030 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.53124414 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49213613 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47140792 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.47048248 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.46615032 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42957291 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40312655 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40241523 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37684785 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35753717 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23524364 |
| 44 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.15947189 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15494361 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14466267 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12523865 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98503099 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98350182 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.97722359 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96374584 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95941072 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 0.94263875 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87672627 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84688353 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83265710 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79617470 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75114705 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74551378 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.70341068 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63123273 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.62120630 |
| 63 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59764751 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48000923 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46946976 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.45874471 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42254461 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41883404 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38656430 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38190416 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34526851 |
| 72 | Homologous recombination_Homo sapiens_hsa03440 | 0.31432629 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31199075 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.31195614 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25501908 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.24629253 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24547929 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20714997 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.17037403 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16946951 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.13519521 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06055149 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.06006082 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04814148 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.03516296 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.03510178 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.02909373 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.00601385 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00410442 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0988222 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0901627 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | -0.0883635 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0789768 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0632809 |
| 95 | Cell cycle_Homo sapiens_hsa04110 | -0.0622286 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0545858 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0511474 |
| 98 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0304571 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0246925 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | -0.0170318 |

